Patents by Inventor Jerry A. Weisbach

Jerry A. Weisbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4584299
    Abstract: Method for treating heart failure by increasing myocardial contractility and cardiac output with the administration of a pharmaceutical composition containing a combination of active ingredients including a pyridazinone or pyridin-one cardiotonic agent and a tetrahydroisoquinoline-3-carboxylic or octahydro-1H-indole-2-carboxylic acid ACE inhibitor.
    Type: Grant
    Filed: May 21, 1984
    Date of Patent: April 22, 1986
    Assignee: Warner-Lambert Company
    Inventors: Robert P. Steffen, Dale B. Evans, Harvey R. Kaplan, Jerry A. Weisbach
  • Patent number: 4582823
    Abstract: A method for treating schizophrenia without precipitating neurological side effects such as extrapyramidal syndrome and tardive dyskinesia by administering prior to or concomitantly with haloperidol a diphenylalkyladenosine or diphenylalkyl-2-amino-adenosine is described as well as pharmaceutical compositions therefor.
    Type: Grant
    Filed: August 15, 1984
    Date of Patent: April 15, 1986
    Assignee: Warner-Lambert Company
    Inventors: Thomas G. Heffner, Stephen E. Harrigan, Jerry A. Weisbach
  • Patent number: 4101657
    Abstract: 7.beta.-Substituted mercaptoacetamido-7.alpha.-methoxycephalosporanic acid and derivatives thereof are prepared. These compounds are antibacterial agents with improved properties.
    Type: Grant
    Filed: July 1, 1977
    Date of Patent: July 18, 1978
    Assignee: SmithKline Corporation
    Inventors: Robert M. DeMarinis, Jerry A. Weisbach
  • Patent number: 4059578
    Abstract: 7.beta.-Substituted mercaptoacetamido-7.alpha.-methoxycephalosporanic acid and derivatives thereof are prepared. These compounds are antibacterial agents with improved properties.
    Type: Grant
    Filed: January 13, 1975
    Date of Patent: November 22, 1977
    Assignee: SmithKline Corporation
    Inventors: Robert M. DeMarinis, Jerry A. Weisbach
  • Patent number: 4048430
    Abstract: Novel pseudodisaccharide compounds which are related to neamine are prepared. These compounds have a mercapto group or a derivative thereof at position 3 or 4 of the glucose moiety of neamine. The compounds have antibacterial activity and have utility as intermediates to pseudotrisaccharides.
    Type: Grant
    Filed: December 18, 1975
    Date of Patent: September 13, 1977
    Assignee: SmithKline Corporation
    Inventors: David J. Cooper, John R. E. Hoover, Jerry A. Weisbach
  • Patent number: 3960838
    Abstract: Novel pseudodisaccharide compounds which are related to neamine are prepared. These compounds have a mercapto group or a derivative thereof at position 3 or 4 of the glucose moiety of neamine. The compounds have antibacterial activity and have utility as intermediates to pseudotrisaccharides.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: June 1, 1976
    Assignee: SmithKline Corporation
    Inventors: David J. Cooper, John R. E. Hoover, Jerry A. Weisbach